Bladder Preservation Strategy Based on Combined Therapy in Patients with Muscle-Invasive Bladder Cancer: Management and Results at Long-Term Follow-Up

Publisher： Karger

E-ISSN： 1423-0399|85|3|281-286

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.85, Iss.3, 2010-07, pp. : 281-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 391-398

Karger

Access to resources Recommend Favorite

Perioperative chemotherapy for muscle‐invasive bladder cancer: A population‐based outcomes study

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1630-1638

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of Care Indicators for Muscle-Invasive Bladder Cancer

By  

Urologia Internationalis, Vol. 86, Iss. 1, 2010-10 ,pp. : 11-18

Karger

Access to resources Recommend Favorite

Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy

By  

Oncology, Vol. 93, Iss. 4, 2017-06 ,pp. : 259-269

Karger

Access to resources Recommend Favorite

Long‐term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow‐up

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 6, 2015-06 ,pp. : 787-795

John Wiley & Sons Inc

Access to resources Recommend Favorite